The Revolutionizing Atopic Dermatitis (RAD) Conference 2025 takes place June 6–7 at the DoubleTree by Hilton Hotel Nashville Downtown Held in partnership with HCPLive® and Dermatology Times ...

What are your key takeaways from this study, and how do the results influence your perspective on long-term options for the treatment of atopic dermatitis? In your current practice, where does ...

2-3 While treatment options for atopic dermatitis are available, many patients remain frustrated and disappointed with the limitations of these options, with 87% of patients seeking freedom from ...

In adults with atopic dermatitis, moisturizers with anti-inflammatory ingredients significantly improved skin hydration and disease severity over two weeks. While moisturizers with and without ...

The Revolutionizing Atopic Dermatitis (RAD) Conference 2025 takes place June 6–7 at the DoubleTree by Hilton Hotel Nashville Downtown, offering cutting-edge updates on the treatment and ...

The Revolutionizing Atopic Dermatitis (RAD) Conference 2025 takes place June 6-7 at the DoubleTree by Hilton Hotel Nashville Downtown, offering cutting-edge updates on the treatment and management of ...

There are a variety of treatment options available for managing atopic dermatitis (AD). Topical corticosteroids remain the gold standard of care, while phototherapy and immunosuppressants may be ...

After a couple of days filled with investor nervousness, Arcutis Biotherapeutics has claimed FDA approval of Zoryve for the new indication of atopic dermatitis (AD), a common form of eczema.

The atopic dermatitis app will launch first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022. Image Phil Taylor ...

Kymera Therapeutics announced new clinical trials for KT-621, targeting atopic dermatitis and asthma, with data expected in 2025 and 2026. Kymera Therapeutics has announced the initiation of ...